Medexus Pharmaceuticals Inc. — Form D

Medexus Pharmaceuticals Inc. of VERDUN, A8, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-13. The offering totals $400K, of which $400K was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2020-03-13
• Form: D
• Accession: 0001806605-20-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $400K
• Amount sold: $400K
• Investors: 1
• Date of first sale: 2020-02-28
• Security types: equity
• Revenue range: $25,000,001 - $100,000,000
• SEC file number: 021-362803

Issuer

• Name: Medexus Pharmaceuticals Inc.
• CIK: 0001806605
• Entity type: Corporation
• Jurisdiction: CANADA (FEDERAL LEVEL)
• Address: 225 - 1 PLACE DU COMMERCE, VERDUN, A8, H3E 1A2
• Phone: 514 762-2626

Officers, directors & promoters (9)

More

• CIK 1806605 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search